商业烟曲霉实时PCR检测用于血液恶性肿瘤患者侵袭性肺曲霉病诊断的临床与分析评估
该研究回顾性分析153例血液恶性肿瘤成人患者的296份血清和136份呼吸道标本,评估商业烟曲霉qPCR对侵袭性肺曲霉病的诊断性能。以一次阳性为诊断标准时敏感性和特异性分别为0.73和0.71,要求两次阳性则敏感性降至0.31、特异性升至0.93,且诊断性能因标本类型而异。分析验证发现与非烟曲霉曲霉及非曲霉霉菌存在交叉反应,提示结果需结合真菌学与临床数据谨慎解读。
要点
- 一次阳性qPCR诊断IPA的敏感性和特异性分别为0.73和0.71,两次阳性则敏感性降至0.31、特异性升至0.93。
- 血液标本敏感性从0.33(一次阳性)降至0.13(两次阳性),特异性从0.73升至0.95。
- 呼吸道标本敏感性从0.70降至0.60,特异性从0.60升至0.87,且存在与其他霉菌的交叉反应。
核心结论
- Af-qPCR在真实临床环境中的诊断性能取决于标本类型和阳性判定标准,且与非烟曲霉曲霉及非曲霉霉菌存在交叉反应。
- Af-qPCR结果应结合真菌学与临床数据谨慎解读。
研究设计与样本
- 回顾性研究,纳入153例血液恶性肿瘤成人患者,分析296份血清和136份呼吸道标本。
- 患者按EORTC/MSGERC标准分类,分别在有或无qPCR结果参与的情况下进行归类。
- 评估qPCR对抗真菌治疗管理的影响,并使用非烟曲霉霉菌DNA评估分析特异性。
主要发现
- 以一次阳性qPCR为IPA诊断标准时,敏感性和特异性分别为0.73和0.71;要求两次阳性时敏感性降至0.31、特异性升至0.93。
- 血液标本中,一次阳性qPCR敏感性0.33、特异性0.73,两次阳性敏感性0.13、特异性0.95。
- 呼吸道标本中,一次阳性qPCR敏感性0.70、特异性0.60,两次阳性敏感性0.60、特异性0.87。
- 4例可能感染患者被重新分类为很可能IPA,并在常规诊疗中接受了抗真菌治疗。
- 分析验证显示与非烟曲霉曲霉及非曲霉霉菌存在交叉反应。
关键数值与推荐
- EORTC/MSGERC将曲霉PCR列为IPA的微生物学标准之一。
- 一次阳性qPCR:敏感性0.73、特异性0.71;两次阳性:敏感性0.31、特异性0.93。
- 血液标本:一次阳性敏感性0.33、特异性0.73;两次阳性敏感性0.13、特异性0.95。
- 呼吸道标本:一次阳性敏感性0.70、特异性0.60;两次阳性敏感性0.60、特异性0.87。
临床怎么用
- 临床解读Af-qPCR结果时需考虑标本类型和所用阳性判定标准(一次或两次阳性)。
- Af-qPCR结果应结合真菌学与临床数据综合判断,避免仅凭PCR阳性作出诊断。
- 需警惕与非烟曲霉曲霉及非曲霉霉菌的交叉反应导致的假阳性。
局限性
- 研究为回顾性设计。
- 分析验证显示与非烟曲霉曲霉及非曲霉霉菌存在交叉反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a severe complication of hematological malignancies. The European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) includes Aspergillus polymerase chain reaction (PCR), as a mycological criterion for IPA. METHODS: We retrospectively studied patients who underwent at least two Aspergillus fumigatus (Af) real-time PCR (qPCR) tests. Patients were classified according to the EORTC/MSGERC definitions, with or without considering qPCR results. We assessed the impact of qPCR on antifungal management and evaluated analytical specificity using non-Af molds DNA. RESULTS: We analyzed 296 serum and 136 respiratory specimens from 153 adults with hematological malignancies.Overall, using one positive qPCR as an IPA diagnostic criterion yielded a sensitivity and specificity of 0.73 and 0.71, respectively, whereas requiring two positive qPCR results reduced sensitivity to 0.31 and increased specificity to 0.93. Diagnostic performance differed according to specimen type. In blood specimens, sensitivity ranged from 0.33 with one positive qPCR result to 0.13 with two positive qPCR results, while specificity increased from 0.73 to 0.95. In respiratory specimens, sensitivity ranged from 0.70 to 0.60, with specificity from 0.60 to 0.87. Four patients with possible infection were reclassified as probable IPA and were treated with antifungals during routine care. Analytical testing revealed cross-reactivity with non-fumigatus Aspergillus species and non-Aspergillus molds. CONCLUSIONS: The performance of Af-qPCR in real-life settings depends on specimen type and positivity criteria. Cross-reactivities with other molds exist. Af-qPCR results should be interpreted cautiously, considering mycological and clinical data.
引用
- Gibert C, Bigot J, Brissot E, et al. Clinical and analytical evaluation of a commercial Aspergillus fumigatus real-time PCR assay for the diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J Infect Dis. 2026. PMID: 42217497. doi:10.1093/infdis/jiag280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。